167 related articles for article (PubMed ID: 7568169)
1. Signaling by ABL oncogenes through cyclin D1.
Afar DE; McLaughlin J; Sherr CJ; Witte ON; Roussel MF
Proc Natl Acad Sci U S A; 1995 Oct; 92(21):9540-4. PubMed ID: 7568169
[TBL] [Abstract][Full Text] [Related]
2. Rescue of defective mitogenic signaling by D-type cyclins.
Roussel MF; Theodoras AM; Pagano M; Sherr CJ
Proc Natl Acad Sci U S A; 1995 Jul; 92(15):6837-41. PubMed ID: 7624328
[TBL] [Abstract][Full Text] [Related]
3. Transformation of hematopoietic cells by BCR/ABL requires activation of a PI-3k/Akt-dependent pathway.
Skorski T; Bellacosa A; Nieborowska-Skorska M; Majewski M; Martinez R; Choi JK; Trotta R; Wlodarski P; Perrotti D; Chan TO; Wasik MA; Tsichlis PN; Calabretta B
EMBO J; 1997 Oct; 16(20):6151-61. PubMed ID: 9321394
[TBL] [Abstract][Full Text] [Related]
4. Alternative signals to RAS for hematopoietic transformation by the BCR-ABL oncogene.
Goga A; McLaughlin J; Afar DE; Saffran DC; Witte ON
Cell; 1995 Sep; 82(6):981-8. PubMed ID: 7553858
[TBL] [Abstract][Full Text] [Related]
5. Two potentially oncogenic cyclins, cyclin A and cyclin D1, share common properties of subunit configuration, tyrosine phosphorylation and physical association with the Rb protein.
Hall FL; Williams RT; Wu L; Wu F; Carbonaro-Hall DA; Harper JW; Warburton D
Oncogene; 1993 May; 8(5):1377-84. PubMed ID: 8479754
[TBL] [Abstract][Full Text] [Related]
6. v-Abl utilizes multiple mechanisms to drive G1/S progression in fibroblasts.
Coutts M; Zou X; Calame K
Oncogene; 2000 Feb; 19(6):801-9. PubMed ID: 10698498
[TBL] [Abstract][Full Text] [Related]
7. Cyclin D1 as a cellular proto-oncogene.
Bates S; Peters G
Semin Cancer Biol; 1995 Apr; 6(2):73-82. PubMed ID: 7647309
[TBL] [Abstract][Full Text] [Related]
8. Critical role for cyclin D2 in BCR/ABL-induced proliferation of hematopoietic cells.
Jena N; Deng M; Sicinska E; Sicinski P; Daley GQ
Cancer Res; 2002 Jan; 62(2):535-41. PubMed ID: 11809706
[TBL] [Abstract][Full Text] [Related]
9. Physical interaction of the retinoblastoma protein with human D cyclins.
Dowdy SF; Hinds PW; Louie K; Reed SI; Arnold A; Weinberg RA
Cell; 1993 May; 73(3):499-511. PubMed ID: 8490963
[TBL] [Abstract][Full Text] [Related]
10. Regulation of cell cycle entry and G1 progression by CSF-1.
Roussel MF
Mol Reprod Dev; 1997 Jan; 46(1):11-8. PubMed ID: 8981358
[TBL] [Abstract][Full Text] [Related]
11. Regulation of the oncogenic activity of BCR-ABL by a tightly bound substrate protein RIN1.
Afar DE; Han L; McLaughlin J; Wong S; Dhaka A; Parmar K; Rosenberg N; Witte ON; Colicelli J
Immunity; 1997 Jun; 6(6):773-82. PubMed ID: 9208849
[TBL] [Abstract][Full Text] [Related]
12. Bcr and Abl interaction: oncogenic activation of c-Abl by sequestering Bcr.
Ling X; Ma G; Sun T; Liu J; Arlinghaus RB
Cancer Res; 2003 Jan; 63(2):298-303. PubMed ID: 12543778
[TBL] [Abstract][Full Text] [Related]
13. 5-hydroxytryptamine 2B receptor regulates cell-cycle progression: cross-talk with tyrosine kinase pathways.
Nebigil CG; Launay JM; Hickel P; Tournois C; Maroteaux L
Proc Natl Acad Sci U S A; 2000 Mar; 97(6):2591-6. PubMed ID: 10688905
[TBL] [Abstract][Full Text] [Related]
14. Oncogenic collaboration of the cyclin D1 (PRAD1, bcl-1) gene with a mutated p53 and an activated ras oncogene in neoplastic transformation.
Uchimaru K; Endo K; Fujinuma H; Zukerberg L; Arnold A; Motokura T
Jpn J Cancer Res; 1996 May; 87(5):459-65. PubMed ID: 8641982
[TBL] [Abstract][Full Text] [Related]
15. Dissection of signaling pathways and cloning of new signal transducers in tyrosine kinase-induced pathways by genetic selection.
Mahlmann S; McLaughlin J; Afar DE; Mohr R; Kay RJ; Witte ON
Leukemia; 1998 Dec; 12(12):1858-65. PubMed ID: 9844916
[TBL] [Abstract][Full Text] [Related]
16. Specific transformation abolishes cyclin D1 fluctuation throughout the cell cycle.
Pusch O; Soucek T; Wawra E; Hengstschläger-Ottnad E; Bernaschek G; Hengstschläger M
FEBS Lett; 1996 May; 385(3):143-8. PubMed ID: 8647239
[TBL] [Abstract][Full Text] [Related]
17. Immortalization of human fibroblasts by SV40 large T antigen results in the reduction of cyclin D1 expression and subunit association with proliferating cell nuclear antigen and Waf1.
Peterson SR; Gadbois DM; Bradbury EM; Kraemer PM
Cancer Res; 1995 Oct; 55(20):4651-7. PubMed ID: 7553644
[TBL] [Abstract][Full Text] [Related]
18. The SH2-containing adapter protein GRB10 interacts with BCR-ABL.
Bai RY; Jahn T; Schrem S; Munzert G; Weidner KM; Wang JY; Duyster J
Oncogene; 1998 Aug; 17(8):941-8. PubMed ID: 9747873
[TBL] [Abstract][Full Text] [Related]
19. BCR sequences essential for transformation by the BCR-ABL oncogene bind to the ABL SH2 regulatory domain in a non-phosphotyrosine-dependent manner.
Pendergast AM; Muller AJ; Havlik MH; Maru Y; Witte ON
Cell; 1991 Jul; 66(1):161-71. PubMed ID: 1712671
[TBL] [Abstract][Full Text] [Related]
20. Tyrosine phosphorylation of p120cbl in BCR/abl transformed hematopoietic cells mediates enhanced association with phosphatidylinositol 3-kinase.
Jain SK; Langdon WY; Varticovski L
Oncogene; 1997 May; 14(18):2217-28. PubMed ID: 9174058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
